McCann FitzGerald LLP has a broad-based healthcare and life sciences practice covering IP and regulatory issues to product liability, licensing, M&A, spin-offs and strategic alliances. It has a particularly strong reputation in product liability cases, having acted for clients in many of the biggest cases over the last 20 years. It has also landed instructions in most of the large patent disputes in the area and has a solid record in medical malpractice and clinical negligence cases. Roddy Bourke is highly-reputed for product liability cases and mass tort claims. Fiona O’Beirne has vast experience in patent disputes in the medical device, pharmaceutical and bio-pharmaceutical sectors, with Shane O’Brien also prominent in this area. David Lydon has an extensive background in life sciences M&A.
Legal 500 redaktioneller Kommentar
- Profil
- Soziale Medien
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Paul Lavery is an excellent lawyer in this area and we find him to be very innovative and solution focused at all times.’
‘I have had the pleasure of working with Fiona O'Beirne and Shane O'Brien. They are very responsive and have ample experience at least in the field of life sciences patent litigation. They have provided us with template drafts of evidence we need to obtain in very short order.'
- 'I have valued the ability to have calls with them at short notice and obtain clear advice during the call. This helps limit costs for the client. ’
Kernmandanten
- Pfizer
- Bristol Meyers Squibb
- VHI
- Biogen MA Inc and Biogen International
- Alkermes Pharma Ireland and Alkermes
- Mainstay Medical Holdings
- Life Healthcare Group Proprietary
- Genuity Science (Ireland)
- Hayfin Capital Management
- Sterimed Infection Control
Highlight-Mandate
- Acted for Bristol-Myers Squibb Holdings Ireland in the defence of a Commercial Court patent/ SPC revocation action brought by Norton (Waterford).
- Successfully represented Biogen in defending Commercial Court patent revocation and infringement proceedings against Neuraxpharm.
- Represented Pfizer in Commercial Court (Intellectual Property and Technology Division) patent proceedings commenced in May 2023 by ModernaTX relating to Pfizer and BioNTech’s Covid-19 vaccine.
Anwält*innen
Hall of fame
Die Anwält*innen an der Spitze ihres Berufsstands, die aufgrund ihres langjährigen Engagements in marktführender Arbeit von Wettbewerbern und Mandanten gleichermaßen geschätzt und anerkannt werden.
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Roddy Bourke; Fiona O’Beirne; David Lydon
Weitere Kernanwält*innen
Paul Lavery; Adam Finlay; Garreth O’Brien; Shane O’Brien; Catherine Derrig